Low 1hPG <8.6 mmol/l (n = 620) | High 1hPG ≥8.6 mmol/l (n = 177) | |||||||
---|---|---|---|---|---|---|---|---|
Non-progressor | Progressor | p values | Non-progressor | Progressor | p values | |||
n = 505 (81%) | n = 115 (19%) | Univariate | Adjusted | n = 109 (62%) | n = 68 (38%) | Univariate | Adjusted | |
At baseline | ||||||||
Men (%) | 37 | 45 | 0.1133 | 0.1243 | 48 | 68 | 0.0101 | 0.0152 |
Age (years) | 42 (36–49) | 46 (39–54) | <0.0001 | <0.0001 | 46 (38–51) | 46 (40–54) | 0.3933 | 0.2194 |
BMI (kg/m2) | 23.8 (21.8–26.2) | 25.2 (23.4–27.8) | 0.0001 | 0.0008 | 24.7 (23.2–27.1) | 26.1 (23.5–28.6) | 0.0383 | 0.0813 |
Diabetes in family (%) | 21 | 23 | 0.6402 | 0.6938 | 28 | 36 | 0.2360 | 0.3143 |
Smoker (%) | 25 | 25 | 0.9938 | 0.4434 | 36 | 33 | 0.6851 | 0.8395 |
FPG (mmol/l) | 4.9 (4.6–5.1) | 5.2 (4.9–5.4) | <0.0001 | <0.0001 | 5.1 (4.8–5.3) | 5.2 (5.1–5.4) | 0.0025 | 0.0154 |
2hPG (mmol/l) | 5.0 (4.3–5.8) | 5.7 (4.8–6.3) | <0.0001 | <0.0001 | 6.1 (5.3–6.9) | 6.4 (5.7–7.0) | 0.1748 | 0.0724 |
LDL-cholesterol (mmol/l) | 2.8 (2.2–3.3) | 2.9 (2.5–3.4) | 0.0576 | 0.8499 | 2.9 (2.4–3.3) | 3.1 (2.6–3.6) | 0.0496 | 0.1773 |
HDL-cholesterol (mmol/l) | 1.5 (1.2–1.7) | 1.3 (1.1–1.6) | 0.0134 | 0.0563 | 1.4 (1.1–1.6) | 1.3 (1.1–1.5) | 0.1311 | 0.9096 |
Triacylglycerol (mmol/l)a | 0.83 (0.62–1.14) | 0.93 (0.68–1.21) | 0.0941 | 0.9211 | 0.91 (0.70–1.15) | 1.12 (0.78–1.66) | 0.0066 | 0.1038 |
Systolic BP (mmHg) | 115 (107–124) | 119 (110–127) | 0.0119 | 0.8486 | 119 (110–125) | 122 (114–130) | 0.0363 | 0.2529 |
Diastolic BP (mmHg) | 73 (67–79) | 75 (70–79) | 0.0792 | 0.6799 | 75 (69–80) | 77 (73–82) | 0.0473 | 0.2378 |
Basal insulin secretion (pmol min−1 m−2)a | 61 (49–78) | 69 (54–92) | 0.0029 | 0.0597 | 65 (48–91) | 86 (68–100) | 0.0005 | 0.0044 |
Total insulin secretion (nmol/m2) | 36 (28–43) | 39 (33–47) | 0.0056 | 0.0623 | 44 (34–55) | 46 (39–55) | 0.1279 | 0.2629 |
BCGS (pmol min−1 m−2 mmol−1 l)a | 133 (100–187) | 134 (99–176) | 0.7585 | 0.9362 | 90 (66–112) | 86 (69–103) | 0.9380 | 0.9380 |
Clamp insulin sensitivity (μmol min−1 kgFFM−1 nmol−1 l)a | 143 (111–194) | 134 (99–181) | 0.1298 | 0.8733 | 133 (90–171) | 95 (75–138) | 0.0016 | 0.0481 |
OGIS (ml min−1 kgFFM−1)a | 12.7 (11.1–14.5) | 11.6 (10.2–12.9) | <0.0001 | 0.0001 | 10.5 (9.6–11.9) | 9.9 (8.7–11.2) | 0.0278 | 0.6382 |
Per cent change over 3 years | ||||||||
BMI | 1.0 (−2.1–4.9) | 2.0 (−1.8–4.8) | 0.7289 | 0.2461 | 1.5 (−2.3–3.7) | 1.4 (0.1–5.1) | 0.3518 | 0.3541 |
Basal insulin secretiona | −0.5 (−18–20) | 14 (−5–38) | 0.0092 | 0.0114 | 4.5 (−14–24) | 11 (−5.8–32) | 0.1049 | 0.0728 |
Total insulin secretiona | 4.8 (−10–24) | 15 (−3–39) | 0.0050 | 0.0550 | −5.3 (−22–12) | 12 (−10–27)) | 0.1110 | 0.2288 |
BCGSa | −8.7 (−37–35) | −15 (−34–12) | 0.3274 | 0.1556 | 24 (−3.7–74) | −2.4 (−21–48) | 0.0302 | 0.0600 |
OGIS | −2.7 (−12–6.9) | −14 (−22–−4.5) | <0.0001 | <0.0001 | 7.7 (−6.9–20) | −13 (−18–−3.5) | <0.0001 | <0.0001 |
Open Access 29.12.2018 | Research Letter
One hour post-load plasma glucose and 3 year risk of worsening fasting and 2 hour glucose tolerance in the RISC cohort
Erschienen in: Diabetologia | Ausgabe 3/2019